Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study
Titel:
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study
Auteur:
Wray, Sibyl Then Bergh, Florian Wundes, Annette Arnold, Douglas L. Drulovic, Jelena Jasinska, Elzbieta Bowen, James D. Negroski, Donald Naismith, Robert T. Hunter, Samuel F. Gudesblatt, Mark Chen, Hailu Lyons, Jennifer Shankar, Sai L. Kapadia, Shivani Mendoza, Jason P. Singer, Barry A.